CASI Pharmaceuticals, Inc.
- Close
- May 15, 2026 · +7.14%
- Market cap
- $3.08M
- 20.56M shares
- Filings
- 157
FY 2025−27.4% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−58.2% FY25 yoy
- $3.08M
- —
- 0.1×
- —
- -673.61%
- —
FY2025 figures · derived
Price
May 15, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $20,712,000 | reported | |
| FY 2024 | 2024-12-31 | $28,537,000 | reported | |
| FY 2023 | 2023-12-31 | $33,879,000 | reported | |
| FY 2022 | 2022-12-31 | $38,047,000 | reported | |
| FY 2021 | 2021-12-31 | $30,020,000 | reported | |
| FY 2020 | 2020-12-31 | $15,001,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $278.00K | $278.00K | — | 13.38M sh | −0.6% | — |
| FY2022 | — | $3.27M | $3.27M | — | 13.46M sh | −3.7% | — |
Pharmaceutical preparations
CASI Pharmaceuticals, Inc. is the 152nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
CELUCelularity Inc$26.6M51.0%345.4%$21.8MTRDAEntrada Therapeutics, Inc.$25.4M87.9%565.5%$203.2MALMSAlumis Inc.$24.1M—1,011.7%$796.5MNAMSNewAmsterdam Pharma Co N.V.$22.5M50.6%905.7%$2.4B
CASIFCASI Pharmaceuticals, Inc. (this company)$20.7M27.4%232.0%$3.1M
SCYXScynexis Inc$20.6M449.9%41.8%$32.9MEVFMEvofem Biosciences, Inc.$20.2M4.2%1.9%$1.3MSLGLSol-Gel Technologies Ltd.$19.4M68.0%31.6%$156.0MZYBTZhengye Biotechnology Holding Ltd$16.6M34.8%60.0%$71.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
CASI Pharmaceuticals, Inc. · CIK 1962738 · Engraved from SEC EDGAR